These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4007251)

  • 1. Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.
    Laher MS; Hickey MP
    J Int Med Res; 1985; 13(3):159-62. PubMed ID: 4007251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formulation on the pharmacokinetics of orally administered pinacidil in humans.
    McBurney A; Farrow PR; Ward JW
    J Pharm Sci; 1987 Dec; 76(12):940-1. PubMed ID: 3440941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
    Ward JW; McBurney A; Farrow PR; Sharp P
    Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers.
    McBurney A; Farrow PR; Ainsworth S; Ward JW
    Br J Clin Pharmacol; 1985 Jan; 19(1):91-4. PubMed ID: 3978025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of food on the bioavailability of sustained-release pinacidil in humans.
    McBurney A; Farrow PR; Ward JW
    J Pharm Sci; 1988 Jan; 77(1):68-9. PubMed ID: 3346824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of pinacidil in normotensive volunteers after repeated doses of a new slow-release tablet formulation.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1999 Jan; 49(1):21-5. PubMed ID: 10028374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and distribution of the new antihypertensive agent pinacidil in rat, dog and man.
    Eilertsen E; Hart JW; Magnussen MP; Sørensen H; Arrigoni-Martelli E
    Xenobiotica; 1982 Mar; 12(3):177-85. PubMed ID: 7113254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of pinacidil on theophylline pharmacokinetics and metabolism in man.
    Nielsen-Kudsk JE; Nielsen CB; Mellemkjaer S; Siggaard C
    Pharmacol Toxicol; 1990 Aug; 67(2):156-8. PubMed ID: 2255669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker.
    von Möllendorff E; Reiff K; Neugebauer G
    Eur J Clin Pharmacol; 1987; 33(5):511-3. PubMed ID: 3428345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
    Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of buflomedil after intravenous and oral administration.
    Rey E; Barrier G; d'Athis P; de Lauture D; Richard MO; Lirzin JP; Sureau C; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):437-41. PubMed ID: 7203720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.
    Carlsen JE; Kardel T; Jensen HA; Tangø M; Trap-Jensen J
    Eur J Clin Pharmacol; 1983; 25(4):557-61. PubMed ID: 6653652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.
    D'Arcy V; Laher M; McCoy D; Sullivan P; Walsh CH; Hickey MP
    Eur J Clin Pharmacol; 1985; 28(3):347-9. PubMed ID: 4007040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration.
    Gundert-Remy U; Weber E; Lam G; Chiou WL; Mann W; Aynilian GH
    Eur J Clin Pharmacol; 1981; 20(6):459-63. PubMed ID: 7286057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of a potassium channel activator (pinacidil) on repolarization parameters in healthy volunteers: a surface ECG study.
    Nony P; Girard P; Arnaud P; Rubel P; Fayn J; de Breyne B; Haugh MC; Girard I; Ferry S; Boissel JP
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):534-9. PubMed ID: 7505354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.